533212 GKB

GKB Ophthalmics Share Price

 

 

Start SIP in GKB

Start SIP
GKB Ophthalmics live price: ₹64.49. It opened at ₹57 vs previous close ₹57; intraday high/low: ₹65/₹57. The 50 & 200 DMA stand at ₹56.82/₹64.49.

GKB Ophthalmics Performance

  • Low
  • ₹57
  • High
  • ₹65
  • 52 Week Low
  • ₹45
  • 52 Week High
  • ₹92
  • Open Price₹57
  • Previous Close₹57
  • Volume4,665
  • 50 DMA₹56.82
  • 100 DMA₹58.63
  • 200 DMA₹64.49

Investment Returns

  • Over 1 Month + 11.79%
  • Over 3 Month + 24.26%
  • Over 6 Month -8.49%
  • Over 1 Year -12.06%

Smart Investing Starts Here Start SIP with GKB Ophthalmics for Steady Growth!

Invest Now

GKB Ophthalmics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -12.9
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 0.6
  • Average True Range
  • 4.97
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.09
  • RSI
  • 50.88
  • MFI
  • 61.67

GKB Ophthalmics Financials

GKB Ophthalmics Technicals

EMA & SMA

Current Price
₹64.49
+ 7.01 (12.2%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹57.03
  • 50 Day
  • ₹56.82
  • 100 Day
  • ₹58.63
  • 200 Day
  • ₹64.49

Resistance and Support

57.39 Pivot Speed
  • R3 62.62
  • R2 60.85
  • R1 59.16
  • S1 55.70
  • S2 53.93
  • S3 52.24

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gkb Ophthalmics has an operating revenue of Rs. 150.29 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of -6% needs improvement, ROE of -13% is poor and needs improvement. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

GKB Ophthalmics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-13 Quarterly Results

GKB Ophthalmics F&O

GKB Ophthalmics Shareholding Pattern

51.13%
1.79%
38.56%
8.52%

About GKB Ophthalmics

  • NSE Symbol
  • GKB
  • BSE Symbol
  • 533212
  • Chairman & Managing Director
  • Mr. K G Gupta
  • ISIN
  • INE265D01015

Similar Stocks to GKB Ophthalmics

GKB Ophthalmics FAQs

GKB Ophthalmics share price is ₹64 As on 18 March, 2026 | 15:42

The Market Cap of GKB Ophthalmics is ₹32.5 Cr As on 18 March, 2026 | 15:42

The P/E ratio of GKB Ophthalmics is -12.9 As on 18 March, 2026 | 15:42

The PB ratio of GKB Ophthalmics is 0.6 As on 18 March, 2026 | 15:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23